MedPath
HSA Product

BUVENTOL EASYHALER 200 mcg/inhalation dose

Product approved by Health Sciences Authority (SG)

Basic Information

BUVENTOL EASYHALER 200 mcg/inhalation dose

POWDER, METERED

Regulatory Information

SIN08675P

April 24, 1996

Prescription Only

Therapeutic

RESPIRATORY (INHALATION)

August 10, 2023

May 30, 2025

XR03AC02

Company Information

ORION PHARMA (SG) PTE. LTD.

ORION PHARMA (SG) PTE. LTD.

Active Ingredients

Detailed Information

Contraindications

**4.3 Contraindications** Known hypersensitivity to salbutamol or to milk proteins (the excipient lactose contains milk proteins) Non-i.v. formulations of salbutamol must not be used to arrest uncomplicated premature labour or threatened abortion.

Indication Information

**4.1 Therapeutic Indications** - Symptomatic treatment of acute asthma attack. - Prevention of exercise-induced bronchospasm. - Symptomatic treatment of bronchial asthma and other conditions, such as bronchitis and emphysema, associated with reversible airways obstruction.

© Copyright 2025. All Rights Reserved by MedPath